2030 Communication Diabetes 
pharmaphorum
NOVEMBER 8, 2022
After years of preparation, Eli Lilly is on the brink of launching a fully connected and personalised diabetes management platform, underpinned by digital technologies. Tighter glucose control is known to reduce the risk of complications of diabetes like cardiovascular disease and nerve damage affecting the eyes and extremities.
European Pharmaceutical Review
DECEMBER 15, 2022
At least one million people living with type 1 and type 2 diabetes in low- to middle-income countries (LMICs), mainly Africa, are set to benefit from Eli Lilly and Company and manufacturer EVA Pharmaceutical’s new collaboration delivering a sustainable supply of high-quality, affordable human and analogue insulin to this population.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Express Pharma
AUGUST 4, 2023
At Novo Nordisk, we are dedicated to tackling chronic diseases by driving change in diabetes, obesity, rare diseases- haemophilia, growth hormone deficiency, etc., Simplifying diabetes care, awareness around obesity and related complications, CVDs and rare diseases like haemophilia continue to be the focus areas for the Indian market.
European Pharmaceutical Review
JANUARY 27, 2023
.” “Efforts to expand access to medicines, especially insulin, are only beneficial when effective cold chain systems are in place to keep them at the right temperature on their way to patients,” commented Leigh Ann Pusey, Executive Vice President of corporate affairs and communications for Lilly.
pharmaphorum
MARCH 2, 2022
Novo Nordisk has made its smart insulin pens available in the UK, giving people treated within the NHS for diabetes access to devices that can monitor and record dosing information for the first time. billion in 2020 to more than $16 billion by 2030, according to GlobalData.
PharmD Live
JUNE 23, 2025
RPM investments projected to exceed $29 billion by 2030 , healthcare executives are demanding clinically validated solutions that streamline billing and maintain unwavering CMS alignment. Is your Remote Patient Monitoring (RPM) program delivering measurable clinical outcomes, audit-ready compliance, and scalable ROI?
Pharmaceutical Technology
JANUARY 11, 2023
By 2030, global spending on digital health is projected to represent 8% of all healthcare expenditure, up from 3% currently 2. Digital therapeutic apps are being built to help manage type 2 diabetes or assist with addiction. The global market size is estimated to be more than $95.3bn 1.
Expert insights. Personalized for you.
64 
Let's personalize your content